Dissecting the contribution of Staphylococcus aureus α-phenol-soluble modulins to biofilm amyloid structure

Patrizia Marinelli1, Irantzu Pallares1,2, Susanna Navarro1,2

  • 1Institut de Biotecnologia i de Biomedicina, Universitat Autònoma de Barcelona, E-08193 Bellaterra, Spain.

Scientific Reports
|October 7, 2016
PubMed

Insights

Phenol soluble modulins (PSMs) are key to Staphylococcus aureus biofilm structure. Not all PSMs form amyloid fibrils; their aggregation depends on sequence and structure, offering new therapeutic targets.

Area of Science:

  • Microbiology
  • Biophysics
  • Structural Biology

Background:

  • Staphylococcus aureus is a major cause of biofilm-associated infections.
  • Phenol soluble modulins (PSMs) are critical effectors in staphylococcal biofilm maturation, forming amyloid-like fibrils.
  • Understanding individual PSM contributions to biofilm structure is crucial for developing targeted therapies.

Purpose of the Study:

  • To investigate the specific role of individual PSMs in Staphylococcus aureus biofilm formation.
  • To determine the factors governing the aggregation propensity and function of different PSMs.
  • To explore potential therapeutic strategies targeting PSM amyloid formation.

Main Methods:

  • Computational analysis of PSM sequences and structures.
  • Biophysical techniques to assess peptide aggregation and fibril formation.
  • In-cell studies to observe PSM behavior within bacterial biofilms.

Main Results:

  • Despite sequence and structural similarities, not all PSMs contribute to amyloid fibril formation.
  • Hydrophobic/hydrophilic balance and helical propensity dictate PSM aggregation and function.
  • Epigallocatechin-3-gallate (EGCG) inhibits amyloidogenic PSM assembly and disassembles preformed fibrils.

Conclusions:

  • PSM function in biofilm structure is more complex than previously assumed, with specific peptides driving amyloid formation.
  • The aggregation propensity of PSMs is governed by intrinsic physicochemical properties.
  • EGCG presents a potential therapeutic agent to disrupt Staphylococcus aureus biofilms by targeting PSM amyloid structures.

Related Concept Videos

Biofilms01:29

Biofilms

Biofilms are complex communities of microorganisms encased in a self-produced extracellular polysaccharide matrix attached to surfaces. These microbial consortia can include single or multiple species, providing enhanced survival benefits by forming organized, multilayered structures.The formation of biofilms occurs through four key stages: attachment, colonization, development, and dispersal.During attachment, free-swimming planktonic cells adhere to a surface, often facilitated by...
1.8K
Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining,...
12.5K
Amyloid Fibrils03:03

Amyloid Fibrils

6.9K
Archaeal Cell Wall01:29

Archaeal Cell Wall

Archaeal cell walls are structurally and compositionally distinct from their bacterial counterparts, lacking the characteristic peptidoglycan layer found in most bacteria. Instead, archaeal cell walls exhibit remarkable diversity, utilizing materials such as pseudomurein, polysaccharides, and proteins to construct their protective outer layers. This structural flexibility is closely tied to archaea's ecological adaptability.S-Layers: The Common Archaeal Cell WallThe S-layer is the most...
1.5K